Orgenesis Inc. Stock
Stocks
ORGS
US68619K3032
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4500 USD | +181.25% |
|
+12.50% | +200.00% |
| 03-26 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2024 | CI |
| 03-25 | Orgenesis Inc. Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 983K 854K 795K 730K 1.38M 93.82M 1.4M 9.37M 3.68M 46.71M 3.69M 3.61M 157M | P/E 2023 |
-0.26x | P/E 2024 | -0.17x |
|---|---|---|---|---|---|
| Enterprise Value | 19.16M 16.66M 15.51M 14.24M 26.88M 1.83B 27.3M 183M 71.73M 911M 71.97M 70.39M 3.05B | EV / Sales 2023 |
71.2x | EV / Sales 2024 | 27x |
| Free-Float |
52.06% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +181.25% | ||
| 1 week | +12.50% | ||
| Current month | -36.62% | ||
| 1 month | +12.50% | ||
| 3 months | +12.50% | ||
| 6 months | -25.00% | ||
| Current year | +200.00% |
| 1 week | 0.4 |  | 0.71 |
| 1 month | 0 | | 0.71 |
| Current year | 0 | | 0.84 |
| 1 year | 0 | | 1 |
| 3 years | 0 | | 11.7 |
| 5 years | 0 | | 54.9 |
| 10 years | 0 | | 168 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sarah Ferber
CTO | Chief Tech/Sci/R&D Officer | 72 | 2012-02-01 |
Vered Caplan
CEO | Chief Executive Officer | 57 | 2013-12-23 |
Douglas Karriker
DFI | Director of Finance/CFO | 51 | 2026-03-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Vered Caplan
CHM | Chairman | 57 | 2014-08-13 |
Itzhak Vider
BRD | Director/Board Member | 64 | 2024-07-07 |
Adam Pelavin
BRD | Director/Board Member | 47 | 2024-10-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/5/25 | Other | 1,200,000 | 23.2142% | |||
| 12/12/24 | Free | Director | 1,500 | 0.0290% | ||
| 12/12/24 | Free | Director | 1,835 | 0.0355% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +181.25% | +12.50% | -55.00% | -95.91% | 6.96M | |
| +0.09% | +2.56% | -16.96% | -4.37% | 183B | |
| -0.37% | +2.62% | -4.42% | -2.61% | 109B | |
| -0.29% | +0.47% | +7.97% | +64.64% | 60.57B | |
| +3.50% | +0.47% | +41.00% | +46.44% | 51.8B | |
| +0.10% | +5.92% | -6.10% | -40.54% | 45.64B | |
| +0.41% | +1.37% | - | - | 33.22B | |
| +11.95% | +16.65% | +5.26% | -31.60% | 31.49B | |
| +0.40% | +3.89% | +42.51% | -8.26% | 24B | |
| -1.22% | +6.69% | +0.67% | +1.96% | 22.26B | |
| Average | +19.58% | +4.37% | +1.66% | -7.81% | 56.12B | |
| Weighted average by Cap. | +0.92% | +3.49% | -0.11% | +4.24% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 530K 461K 429K 394K 744K 50.59M 755K 5.05M 1.98M 25.19M 1.99M 1.95M 84.46M | 1.03M 900K 837K 769K 1.45M 98.8M 1.47M 9.87M 3.87M 49.19M 3.89M 3.8M 165M |
| Net income | -55.36M -48.13M -44.79M -41.13M -77.66M -5.28B -78.87M -528M -207M -2.63B -208M -203M -8.82B | -48.16M -41.87M -38.97M -35.78M -67.57M -4.6B -68.62M -459M -180M -2.29B -181M -177M -7.68B |
| Net Debt | 21.78M 18.94M 17.63M 16.18M 30.56M 2.08B 31.03M 208M 81.54M 1.04B 81.81M 80.01M 3.47B | 18.18M 15.8M 14.71M 13.51M 25.51M 1.74B 25.9M 173M 68.06M 864M 68.28M 66.78M 2.9B |
Employees
77
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | US$0.7100 | +77.50% | 100 |
| 26-07-29 | US$0.4000 | -.--% | 100 |
| 26-07-27 | US$0.4000 | -.--% | 100 |
- Stock Market
- Stocks
- ORGS Stock
Select your edition
All financial news and data tailored to specific country editions
